Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said its shareholders overwhelmingly endorsed two remuneration-related resolutions at the company’s first extraordinary general meeting for FY2026, held on Jul, 31 2026 in Tianjin and via video link to Singapore.

Resolution 1, which sought approval for the adoption of a new remuneration policy for directors and senior management, was passed with 99.862% of votes in favour (333.0 million shares), 0.052% against (0.17 million shares) and 0.086% forfeited (0.29 million shares).

Resolution 2, covering the directors’ remuneration proposal for 2026, secured 99.861% of votes in favour (333.0 million shares), 0.054% against (0.18 million shares) and 0.085% forfeited (0.29 million shares). Director Zhou Hong, who holds 23,800 restricted A-shares, abstained from voting on this resolution.

The company’s legal counsel confirmed that the meeting was convened and conducted in compliance with all relevant regulations and that the voting procedures and results were valid.

With no further business, the meeting was adjourned at 4:05 p.m. local time.